Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors

References

• Holub BJ. Metabolism and function of myo-inositol and inositol phospholipids. Annu Rev Nutr. 1986;6(1):563–597.
   PubMedGoogle Scholar
• Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1(1):11–21.
   PubMed Web of Science ®Google Scholar
• Chakraborty A, Kim S, Snyder SH. Inositol pyrophosphates as mammalian cell signals. Sci Signal. 2011;4(188):re1.
   PubMed Web of Science ®Google Scholar
• Hatch AJ, York JD. Snapshot: inositol phosphates. Cell. 2010;143(6):1030.e1.
   Web of Science ®Google Scholar
• Shears SB, Wang H. Inositol phosphate kinases: Expanding the biological significance of the universal core of the protein kinase fold. Adv Biol Regul. 2019;71:118–127.
   PubMedGoogle Scholar
• Lee B, Park SJ, Hong S, Kim K, Kim S. Inositol polyphosphate multikinase signaling: multifaceted functions in health and disease. Mol Cells. 2021;44(4):187–194.
   Google Scholar
• Lee S, Kim M-G, Ahn H, Kim S. Inositol pyrophosphates: signaling molecules with pleiotropic actions in mammals. Molecules. 2020;25(9):2208.
   PubMed Web of Science ®Google Scholar
• Saiardi A, Erdjument-Bromage H, Snowman AM, Tempst P, Snyder SH. Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases. Curr Biol. 1999;9(22):1323–1326.
   PubMed Web of Science ®Google Scholar
• Saiardi A, Nagata E, Luo HR, Snowman AM, Snyder SH. Identification and characterization of a novel inositol hexakisphosphate kinase. J Biol Chem. 2001;276(42):39179–39185.
   PubMed Web of Science ®Google Scholar
• Choi JH, Williams J, Cho J, Falck JR, Shears SB. Purification, sequencing, and molecular identification of a mammalian PP-insP5 kinase that is activated when cells are exposed to hyperosmotic stress. J Biol Chem. 2007;282(42):30763–30775.
   PubMed Web of Science ®Google Scholar
• Fridy PC, Otto JC, Dollins DE, York JD. Cloning and characterization of two human VIP1-like inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinases. J Bio Chem. 2007;282(42):30754–30762.
   PubMed Web of Science ®Google Scholar
• Kilari RS, Weaver JD, Shears SB, Safrany ST. Understanding inositol pyrophosphate metabolism and function: kinetic characterization of the dipps. FEBS Lett. 2013;587(21):3464–3470.
   PubMed Web of Science ®Google Scholar
• Gu C, Wilson MSC, Jessen HJ, Saiardi A, Shears SB. Inositol pyrophosphate profiling of two HCT116 cell lines uncovers variation in insp(8) levels. PLoS One. 2016;11(10):e0165286.
   PubMed Web of Science ®Google Scholar
• Chakraborty A, Koldobskiy MA, Bello NT, Maxwell M, Potter JJ, Juluri KR, Maag D, Kim S, Huang AS, Dailey MJ, et al. Inositol pyrophosphates inhibit akt signaling, thereby regulating insulin sensitivity and weight gain. Cell. 2010;143(6):897–910.
   PubMed Web of Science ®Google Scholar
• Lee T-S, Lee J-Y, Kyung JW, Yang Y, Park SJ, Lee S, Pavlovic I, Kong B, Jho YS, Jessen HJ, et al. Inositol pyrophosphates inhibit synaptotagmin-dependent exocytosis. Proc Natl Acad Sci USA. 2016;113(29):8314–8319.
   PubMed Web of Science ®Google Scholar
• Chin AC, Gao Z, Riley AM, et al. The inositol pyrophosphate 5-insp(7) drives sodium-potassium pump degradation by relieving an autoinhibitory domain of PI3K p85 alpha. Sci Adv. 2020;6:eabb8542.
   PubMed Web of Science ®Google Scholar
• Rao F, Cha J, Xu J, Xu R, Vandiver MS, Tyagi R, Tokhunts R, Koldobskiy MA, Fu C, Barrow R, et al. Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2. Mol Cells. 2014;54(1):119–132.
   Google Scholar
• Saiardi A, Bhandari R, Resnick AC, Snowman AM, Snyder SH. Phosphorylation of proteins by inositol pyrophosphates. Science. 2004;306(5704):2101–2105.
   PubMed Web of Science ®Google Scholar
• Saiardi A. Protein pyrophosphorylation: Moving forward. Biochem J. 2016;473(21):3765–3768.
   PubMedGoogle Scholar
• Mukherjee S, Haubner J, Chakraborty A. Targeting the inositol pyrophosphate biosynthetic enzymes in metabolic diseases. Molecules. 2020;25(6):1403.
   PubMed Web of Science ®Google Scholar
• Wormald MM, Ernst G, Wei H, Barrow JC. Synthesis and characterization of novel isoform-selective IP6K1 inhibitors. Bioorg Med Chem. 2019;29(19):126628.
   Web of Science ®Google Scholar
• Padmanabhan U, Dollins DE, Fridy PC, York JD, Downes CP. Characterization of a selective inhibitor of inositol hexakisphosphate kinases use in defining biological roles and metabolic relationships of inositol pyrophosphates. J Biol Chem. 2009;284(16):10571–10582.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Mukherjee S, Huang D, Chakraborty M, Gu C, Zong G, Stashko MA, Pearce KH, Shears SB, Chakraborty A, et al. Development of novel IP6K inhibitors for the treatment of obesity and obesity-induced metabolic dysfunctions. J Med Chem. 2022;65(9):6869–6887.
   PubMed Web of Science ®Google Scholar
• Gu C, Stashko MA, Puhl-Rubio AC, Chakraborty M, Chakraborty A, Frye SV, Pearce KH, Wang X, Shears SB, Wang H, et al. Inhibition of inositol polyphosphate kinases by quercetin and related flavonoids: a structure-activity analysis. J Med Chem. 2019;62(3):1443–1454.
   PubMed Web of Science ®Google Scholar
• Liao G, Ye W, Heitmann T, Ernst G, DePasquale M, Xu L, Wormald M, Hu X, Ferrer M, Harmel RK, et al. Identification of small-molecule inhibitors of human inositol hexakisphosphate kinases by high-throughput screening. ACS Pharmacol Transl Sci. 2021;4(2):780–789.
   PubMedGoogle Scholar
• Lee S, Park BB, Kwon H, Kim V, Jeon JS, Lee R, Subedi M, Lim T, Ha H, An D, et al. TNP and its analogs: modulation of IP6K and CYP3A4 inhibition. J Enzyme Inhib Med Chem. 2022;37(1):269–279.
   PubMed Web of Science ®Google Scholar
• Puhl-Rubio AC, Stashko MA, Wang H, Hardy PB, Tyagi V, Li B, Wang X, Kireev D, Jessen HJ, Frye SV, et al. Use of protein kinase-focused compound libraries for the discovery of new inositol phosphate kinase inhibitors. Slas Disc. 2018;23(9):982–988.
   PubMed Web of Science ®Google Scholar
• Moritoh Y, Abe S-i, Akiyama H, Kobayashi A, Koyama R, Hara R, Kasai S, Watanabe M. The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammals. Nat Commun. 2021;12(1):4847.
   PubMed Web of Science ®Google Scholar
• Ghoshal S, Zhu Q, Asteian A, Lin H, Xu H, Ernst G, Barrow JC, Xu B, Cameron MD, Kamenecka TM, et al. TNP [N2-(m-trifluorobenzyl), N6-(p-nitrobenzyl) purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway. Mol Metab. 2016;5(10):903–917.
   PubMed Web of Science ®Google Scholar
• Chang Y-T, Choi G, Bae Y-S, Burdett M, Moon H-S, Lee JW, Gray NS, Schultz PG, Meijer L, Chung S-K, et al. Purine-based inhibitors of inositol-1,4,5-trisphosphate-3-kinase. ChemBioChem. 2002;3(9):897–901.
   PubMed Web of Science ®Google Scholar
• Sekar MC, Shahiwala K, Leloup L, Wells A. Modulation of epidermal growth factor stimulated erk phosphorylation and cell motility by inositol trisphosphate kinase. J Pharmaceut Sci Pharmacol. 2014;1(2):160–164.
   PubMedGoogle Scholar
• Terao Y, Takahashi M, Hara R, et al. Preparation of 4-aryloxy-2′-oxo-1′,2′- dihydrospiro[cyclohexane-1,3′-indole]-5′-carboxylic acid and 4-aryloxy-2′-oxo-1′,2′-dihydrospiro[cyclohexane-1,3′-pyrrolo[3,2-b]- pyridine]-5′-carboxylic acid derivatives as IP6K inhibitors. WO2018182051 A1, 2018.
   Google Scholar
• Park BB, Choi JW, Park D, Choi D, Paek J, Kim HJ, Son S-Y, Mushtaq AU, Shin H, Kim SH, et al. Structure-activity relationships of baicalein and its analogs as novel tslp inhibitors. Sci Rep. 2019;9(1):8762.
   PubMedGoogle Scholar
• Britton RG, Horner-Glister E, Pomenya OA, Smith EE, Denton R, Jenkins PR, Steward WP, Brown K, Gescher A, Sale S, et al. Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents. Eur J Med Chem. 2012;54:952–958.
   PubMed Web of Science ®Google Scholar
• Vasselin DA, Westwell AD, Matthews CS, Bradshaw TD, Stevens MFG. Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4h-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzothiazoles. J Med Chem. 2006;49(13):3973–3981.
   PubMed Web of Science ®Google Scholar
• Oh MH, Lee HJ, Jo SH, Park BB, Park S-B, Kim E-y, Zhou Y, Jeon YH, Lee K. Development of cassette pampa for permeability screening. Biol Pharm Bull. 2017;40(4):419–424.
   PubMed Web of Science ®Google Scholar
• Koldobskiy MA, Chakraborty A, Werner JK, Snowman AM, Juluri KR, Vandiver MS, Kim S, Heletz S, Snyder SH. Jr,. P53-mediated apoptosis requires inositol hexakisphosphate kinase-2. Proc Natl Acad Sci USA. 2010;107(49):20947–20951.
   PubMed Web of Science ®Google Scholar
• Yokoyama T, Kosaka Y, Mizuguchi M. Structural insight into the interactions between death-associated protein kinase 1 and natural flavonoids. J Med Chem. 2015;58(18):7400–7408.
   PubMed Web of Science ®Google Scholar
• Azevedo C, Saiardi A. Extraction and analysis of soluble inositol polyphosphates from yeast. Nat Protoc. 2006;1(5):2416–2422.
   PubMed Web of Science ®Google Scholar